Raymond James Financial Services Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $66.2M | Sell |
|
|||||
|
2024
Q2 | $85.6M | Buy |
|
|||||
|
2024
Q1 | $69.5M | Buy |
|
|||||
|
2023
Q4 | $50.6M | Buy |
|
|||||
|
2023
Q3 | $32.7M | Buy |
|
|||||
|
2023
Q2 | $23.7M | Sell |
|
|||||
|
2023
Q1 | $24.9M | Buy |
|
|||||
|
2022
Q4 | $16.3M | Buy |
|
|||||
|
2022
Q3 | $11M | Sell |
|
|||||
|
2022
Q2 | $13.7M | Sell |
|
|||||
|
2022
Q1 | $18.6M | Buy |
|
|||||
|
2021
Q4 | $18.3M | Buy |
|
|||||
|
2021
Q3 | $15.7M | Buy |
|
|||||
|
2021
Q2 | $13.4M | Buy |
|
|||||
|
2021
Q1 | $10.6M | Buy |
|
|||||
|
2020
Q4 | $7.69M | Sell |
|
|||||
|
2020
Q3 | $13.4M | Buy |
|
|||||
|
2020
Q2 | $8.82M | Buy |
|
|||||
|
2020
Q1 | $5.78M | Buy |
|
|||||
|
2019
Q4 | $5.35M | Buy |
|
|||||
|
2019
Q3 | $4.6M | Sell |
|
|||||
|
2019
Q2 | $6.18M | Sell |
|
|||||
|
2019
Q1 | $6.74M | Buy |
|
|||||
|
2018
Q4 | $5.91M | Sell |
|
|||||
|
2018
Q3 | $6.93M | Buy |
|
|||||
|
2018
Q2 | $6.71M | Buy |
|
|||||
|
2018
Q1 | $5.05M | Buy |
|
|||||
|
2017
Q4 | $4.92M | Buy |
|
|||||
|
2017
Q3 | $3.98M | Sell |
|
|||||
|
2017
Q2 | $3.94M | Buy |
|
|||||
|
2017
Q1 | $3.11M | Sell |
|
|||||
|
2016
Q4 | $7.51M | Buy |
|
|||||
|
2016
Q3 | $8.56M | Buy |
|
|||||
|
2016
Q2 | $11M | Sell |
|
|||||
|
2016
Q1 | $11.2M | Buy |
|
|||||
|
2015
Q4 | $11.8M | Buy |
|
|||||
|
2015
Q3 | $10.7M | Buy |
|
|||||
|
2015
Q2 | $4.82M | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $4.05M | Buy |
|